These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 33210537)

  • 1. Computational Fragment-Based Design Facilitates Discovery of Potent and Selective Monoamine Oxidase-B (MAO-B) Inhibitor.
    Jin CF; Wang ZZ; Chen KZ; Xu TF; Hao GF
    J Med Chem; 2020 Dec; 63(23):15021-15036. PubMed ID: 33210537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing monoamine oxidase B inhibitory activity via chiral fluorination: Structure-activity relationship, biological evaluation, and molecular docking study.
    Wang Z; Yi C; Chen K; Wang T; Deng K; Jin C; Hao G
    Eur J Med Chem; 2022 Jan; 228():114025. PubMed ID: 34871839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoamine oxidase.
    Leonetti F; Capaldi C; Pisani L; Nicolotti O; Muncipinto G; Stefanachi A; Cellamare S; Caccia C; Carotti A
    J Med Chem; 2007 Oct; 50(20):4909-16. PubMed ID: 17824599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies.
    Elkamhawy A; Paik S; Park JH; Kim HJ; Hassan AHE; Lee K; Park KD; Roh EJ
    Bioorg Chem; 2021 Oct; 115():105233. PubMed ID: 34390968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-[2-(4-Benzyloxyphenoxy)Ethyl]Imidazole inhibits monoamine oxidase B and protects against neuronal loss and behavioral impairment in rodent models of Parkinson's disease.
    Chung JY; Lee JW; Ryu CH; Min HK; Yoon YJ; Lim MJ; Park CH
    J Neurosci Res; 2015 Aug; 93(8):1267-78. PubMed ID: 25711470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of biaryl derivatives for structural characterization of selective monoamine oxidase B inhibitors toward Parkinson's disease therapy.
    Yeon SK; Choi JW; Park JH; Lee YR; Kim HJ; Shin SJ; Jang BK; Kim S; Bahn YS; Han G; Lee YS; Pae AN; Park KD
    Bioorg Med Chem; 2018 Jan; 26(1):232-244. PubMed ID: 29198609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S; Zheng H; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
    La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
    J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of transcription factor SP1 produces neuroprotective effects through decreasing MAO B activity in MPTP/MPP
    Yao L; Dai X; Sun Y; Wang Y; Yang Q; Chen X; Liu Y; Zhang L; Xie W; Liu J
    J Neurosci Res; 2018 Oct; 96(10):1663-1676. PubMed ID: 30004136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ro 16-6491: a new reversible and highly selective MAO-B inhibitor protects mice from the dopaminergic neurotoxicity of MPTP.
    Da Prada M; Kettler R; Keller HH; Bonetti EP; Imhof R
    Adv Neurol; 1987; 45():175-8. PubMed ID: 2881442
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW; Robertson DW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists.
    Petzer JP; Steyn S; Castagnoli KP; Chen JF; Schwarzschild MA; Van der Schyf CJ; Castagnoli N
    Bioorg Med Chem; 2003 Apr; 11(7):1299-310. PubMed ID: 12628657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
    Legoabe LJ; Petzer A; Petzer JP
    Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors.
    Mellado M; González C; Mella J; Aguilar LF; Viña D; Uriarte E; Cuellar M; Matos MJ
    Bioorg Chem; 2021 Mar; 108():104689. PubMed ID: 33571810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxytyrosol as anti-parkinsonian molecule: Assessment using in-silico and MPTP-induced Parkinson's disease model.
    Pathania A; Kumar R; Sandhir R
    Biomed Pharmacother; 2021 Jul; 139():111525. PubMed ID: 33882412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors.
    Choi JW; Jang BK; Cho NC; Park JH; Yeon SK; Ju EJ; Lee YS; Han G; Pae AN; Kim DJ; Park KD
    Bioorg Med Chem; 2015 Oct; 23(19):6486-96. PubMed ID: 26337020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, monoamine oxidase inhibitory activity and computational study of novel isoxazole derivatives as potential antiparkinson agents.
    Agrawal N; Mishra P
    Comput Biol Chem; 2019 Apr; 79():63-72. PubMed ID: 30731360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxazolopyridines and thiazolopyridines as monoamine oxidase B inhibitors for the treatment of Parkinson's disease.
    Park HR; Kim J; Kim T; Jo S; Yeom M; Moon B; Choo IH; Lee J; Lim EJ; Park KD; Min SJ; Nam G; Keum G; Lee CJ; Choo H
    Bioorg Med Chem; 2013 Sep; 21(17):5480-7. PubMed ID: 23810676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel selective MAO-B inhibitor with neuroprotective and anti-Parkinsonian properties.
    Chan HH; Tse MK; Kumar S; Zhuo L
    Eur J Pharmacol; 2018 Jan; 818():254-262. PubMed ID: 29050969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.
    Tzvetkov NT; Stammler HG; Neumann B; Hristova S; Antonov L; Gastreich M
    Eur J Med Chem; 2017 Feb; 127():470-492. PubMed ID: 28107736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.